Biotechnology

Genome Language Modeling (GLM) Market Size, Share & Trends Analysis Distribution, by Type (Encoder-Based GLMs, Decoder-Based GLMs, and Hybrid/Multimodal GLMs), by Application (Disease Gene Prediction, Variant Pathogenicity Assessment, Functional Genomics Annotation, Clinical Diagnostics, Drug Discovery & Development, and Agricultural Genomics), by End User (Academic & Research Institutes, Pharmaceutical Companies, Hospitals, and Biotech Firms), by Product (Software Tools, Cloud Analytics Platforms, Custom Genomic Models), and Segment Forecasts, 2025-2034

Global Genome Language Modeling (GLM) Market Size is valued at US$ 31.2 Bn in 2024 and is predicted to reach US$ 101.6 Bn by the year 2034 at an 12.9% CAGR during the forecast period for 2025-2034. The study of complex sequences of genetic material is referred to as genome language modeling (GLM), and is a process by means of which we can more accurately determine gene function, recognize mutations, and gain insight into regulatory processes. GL...

Report ID: 3232  |  

Delivery: Immediate  |  

Published: October 2025   |  

No. of Pages: 180

Click Chemistry and Bioorthogonal Chemistry Market Size, Share & Trends Analysis Distribution By Type of Click Chemistry Reaction (CuAAC Reaction, SPAAC Reaction, Diels-Alder Reaction, Thiol-ene Reaction and Other Click Chemistry Reactions), By Type of Molecule (Peptide/Protein, Oligonucleotide Antibody Drug Conjugate, Antibody, Small Molecule, Radiopharmaceutical and Other Molecules), By Application Area (Drug Discovery, Drug Synthesis, and Other Application Areas) and Segment Forecasts, 2025-2034

Click Chemistry and Bioorthogonal Chemistry Market Size is valued at US$ 1.0 Bn in 2024 and is predicted to reach US$ 2.2 Bn by the year 2034 at an 8.1% CAGR during the forecast period for 2025-2034. Click chemistry and bioorthogonal chemistry involve fast, selective, high-yielding reactions that occur under mild, biocompatible conditions, enabling efficient molecular assembly and in vivo labeling without disrupting native biological processes...

Report ID: 3226  |  

Delivery: Immediate  |  

Published: October 2025   |  

No. of Pages: 180

Microbial Fermentation CMO Market Size, Share & Trends Analysis Distribution by Type of Expression System (Bacterial Expression Systems, Yeast Expression Systems and Other Expression Systems), Type of Biologic (Recombinant Proteins, Enzymes, Plasmid DNA, Antibodies and Others), Company Size (Small, Mid-sized, Large and Very Large), End-User (Pharma/Biotech Companies and Academic/ Research Institutes) and Segment Forecasts, 2025-2034

Microbial Fermentation CMO Market Size is valued at US$ 3.9 Bn in 2024 and is predicted to reach US$ 6.4 Bn by the year 2034 at an 5.2% CAGR during the forecast period for 2025-2034. A Microbial Fermentation CMO (Contract Manufacturing Organization) is a specialized partner that produces commercial-scale products—such as therapeutics, enzymes, or food ingredients—using bacteria, yeast, or other microorganisms in large bio...

Report ID: 3194  |  

Delivery: Immediate  |  

Published: September 2025   |  

No. of Pages: 180

NGS-Based RNA-Sequencing Market Size, Share & Trends Analysis Distribution by Type (Targeted RNA Sequencing, mRNA Sequencing, Total RNA Sequencing, Single-cell RNA Sequencing (scRNA-Seq), De Novo Transcriptome Assembly , and Non-coding RNA Sequencing (miRNA, lncRNA, circRNA)), Workflow Component, Technology, Application, End-user, and Segment Forecasts, 2025-2034

Global NGS-Based RNA-Sequencing Market Size is valued at US$ 3.6 Bn in 2024 and is predicted to reach US$ 20.3 Bn by the year 2034 at an 19.2% CAGR during the forecast period for 2025-2034. Next-Generation Sequencing (NGS)-based RNA sequencing, or RNA-Seq, is a modern laboratory technique that uses high-throughput sequencing machines to analyze the quantity and sequences of RNA in a biological sample. By converting RNA into DNA and sequencing it...

Report ID: 3186  |  

Delivery: Immediate  |  

Published: September 2025   |  

No. of Pages: 180

Residual DNA Testing Market Size, Share & Trends Analysis Distribution by Offering (Product {Consumables, and Instruments & Software}, and Services), by Test Type (Final Product Release Testing, Bulk Lot Release Testing, and Raw Material Testing), By Technology (Polymerase Chain Reaction, Threshold Assay, DNA Probe Hybridization, and Other Technologies), By Application (Monoclonal Antibodies, Cell & Gene Therapy, Vaccines, And Other Applications), By End-User (Pharmaceutical & Biotechnology Companies, CROS & CDMOS, And Academic & Research Institutes) and Segment Forecasts, 2025-2034

Residual DNA Testing Market Size is valued at US$ 0.25 Bn in 2024 and is predicted to reach US$ 0.54 Bn by the year 2034 at an 8.1% CAGR during the forecast period for 2025-2034. Residual DNA testing is a quality control process used in biopharmaceuticals and vaccines to detect, measure, and ensure safe levels of host-cell DNA remaining after production, maintaining product safety, purity, and regulatory compliance standards. Rising biopharmaceu...

Report ID: 3191  |  

Delivery: Immediate  |  

Published: September 2025   |  

No. of Pages: 180

Host Cell Protein Testing Market Size, Share & Trends Analysis Distribution by Service Type (HCP Assay Development, ELISA Reagent Customization, Anti-HCP Antibody Generation, Orthogonal Method Support, Product Stage (Preclinical, Clinical (Phase I, Phase II, Phase III), and Commercial), Technology (Enzyme-Linked Immunosorbent Assay (ELISA), 2D Gel Electrophoresis, Western Blotting, Liquid Chromatography – Mass Spectrometry (LC-MS/MS), Others), Application (Vaccines, Monoclonal Antibodies (mAbs), Enzymes, Gene Therapy Products, Biosimilars, Recombinant Proteins), Expression System (Insect Cells, Mammalian Cells, Microbial Cells), End-use (Academic & Research Institutions, Biopharmaceutical & Biotechnology Companies, Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs)), and Segment Forecasts, 2025-2034

Global Host Cell Protein Testing Market Size is valued at US$ 2.2 Bn in 2024 and is predicted to reach US$ 4.5 Bn by the year 2034 at an 7.5% CAGR during the forecast period for 2025-2034. Host Cell Proteins, or HCPs, are process-associated protein contaminants that the host bacterium produces during the manufacturing and development of biotherapeutics. It has emerged as a crucial step in the production of biopharmaceuticals, ensuring the safety...

Report ID: 3180  |  

Delivery: Immediate  |  

Published: September 2025   |  

No. of Pages: 170

Cell Banking Outsourcing Market Size, Share & Trends Analysis Distribution, By Service Type (Cell Line Expansion & Banking, Cell Line Characterization & Testing, Cryopreservation & Storage, Regulatory Support (CMC Documentation, Release Testing), Biosafety Testing (Sterility, Mycoplasma, Adventitious Agents), and Others), By Cell Type (Mammalian Cells (CHO Cells, BHK Cells, Vero Cells, HEK 293 Cells, Others), Stem Cells (Induced Pluripotent Stem Cells (iPSCs), Mesenchymal Stem Cells (MSCs), Embryonic Stem Cells (ESCs)), Microbial Cells (Yeast Cells, E. coli, Others), Hybridoma Cells, and Others (e.g., Insect Cells, Primary Cells)), By Bank Type, By Application, By Phase, By End-use, By Region and Segment Forecasts, 2025-2034

Cell Banking Outsourcing Market Size is valued at US$ 14.2 Bn in 2024 and is predicted to reach US$ 65.5 Bn by the year 2034 at an 16.8% CAGR during the forecast period for 2025-2034. A cell bank is a facility that keeps cells that have been taken from different body fluids and organ tissue in order to meet future demands. The ability to preserve cells with a specific genome for later use is known as cell banking outsourcing. In addition to re...

Report ID: 3170  |  

Delivery: Immediate  |  

Published: August 2025   |  

No. of Pages: 180

Regulatory T-Cell (Tregs) Therapies Market Size, Share & Trends Analysis Report Therapeutic Area (Autoimmune Disorders, Oncological Disorders, Post-Transplant Infection, Neurological Disorders, Metabolic Disorders, Dermatological Disorders), by Products (Tregs, Interleukin 2, Monoclonal Antibodies, Small Molecules, CAR-Treg, Other Products), by Source of T-Cells (Autologous, Allogeneic), By Region, And By Segment Forecasts, 2026-2035

Regulatory T cells (Tregs) are T cells that function to regulate other cells in the immune system through various contact-dependent and independent mechanisms. They are vital in preventing and controlling excessive immune responses and autoimmunity. As of now, there is no approved marketed product available in the global market for Regulatory T-Cell Therapies. Based on our estimates, Regulatory T-Cell (Tregs) Therapies Market is estimated to...

Report ID: 1200  |  

Delivery: Immediate  |  

Published: August 2025   |  

No. of Pages: 160

Biotechnology Contract Manufacturing Market Size, Share & Trends Analysis Report By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Other services), By Type, By Scale of Operation , By Source, By Molecule, By Therapeutic Area, By Region, And By Segment Forecasts, 2025-2034

Global Biotechnology Contract Manufacturing Market Size is valued at USD 20.5 Bn in 2024 and is predicted to reach USD 46.6 Bn by the year 2034 at a 8.7% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The growing usage of biologics in a variety of therapeutic applications is likely to drive growth in the Biotechnology Contract Manufacturing market. The increased need for personalized medi...

Report ID: 2067  |  

Delivery: Immediate  |  

Published: July 2025   |  

No. of Pages: 179

Image-Based Cytometry in Cell Analysis Market Size, Share & Trends Analysis Report By End-user (Biotechnology & Pharmaceutical Companies, Academia, Cosmetic Industry, Contract Research Organizations, and Contract Development & Manufacturing Organizations), Region And Segment Forecasts, 2025-2034

Global Image-Based Cytometry In Cell Analysis Market Size is valued at USD 3.8 Bn in 2024 and is predicted to reach USD 9.7 Bn by the year 2034 at a 10.0% CAGR during the forecast period for 2025-2034. Cytometry is the science of determining cell identities through numerical analysis. The cytometer can evaluate many different cell characteristics, such as their size, shape, DNA content, and progression through the cell cycle. The most convention...

Report ID: 2079  |  

Delivery: Immediate  |  

Published: July 2025   |  

No. of Pages: 180

Categories